Clinical Trials Directory

Trials / Completed

CompletedNCT02127320

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Hanmi Pharmaceutical Company Limited · Industry
Sex
Male
Age
19 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the pharmacokinetic drug interactions between Rosuvastatin and Ezetimibe in Healthy Male Subjects

Conditions

Interventions

TypeNameDescription
DRUGRosuvastatin 20mg
DRUGEzetimibe 10mg
DRUGRosuvastatin 20mg + Ezetimibe 10mg

Timeline

Start date
2014-06-01
Primary completion
2014-09-01
Completion
2014-11-01
First posted
2014-04-30
Last updated
2016-10-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02127320. Inclusion in this directory is not an endorsement.